Personalis, Inc. Segment Reporting Other Item Amount
Personalis, Inc. (PSNL) reported Segment Reporting Other Item Amount of $15.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-04
- Personalis, Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $15.55M, a 112.10% increase year-over-year.
- Personalis, Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $12.04M, a 50.24% increase year-over-year.
- Personalis, Inc. segment reporting other item amount for the quarter ending 2025-12-31 was $11.50M, a 53.94% increase year-over-year.
- Personalis, Inc. segment reporting other item amount for the quarter ending 2025-09-30 was $7.24M, a 38.33% decline year-over-year.
- Personalis, Inc. segment reporting other item amount for fiscal 2025 was $34.09M, a 4.86% decline from fiscal 2024.
- Personalis, Inc. segment reporting other item amount for fiscal 2024 was $35.83M, a 137.16% increase from fiscal 2023.
- Personalis, Inc. segment reporting other item amount for fiscal 2023 was $15.11M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.55M 10-Q · filed 2026-08-04 | $27.59M 10-Q · filed 2026-08-04 | $39.09M derived: sum of 3 quarters · filed 2026-08-04 | $46.34M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $12.04M 10-Q · filed 2026-05-07 | $23.54M derived: sum of 2 quarters · filed 2026-05-07 | $30.79M derived: sum of 3 quarters · filed 2026-05-07 | $38.12M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $18.75M derived: sum of 2 quarters · filed 2026-02-26 | $26.08M derived: sum of 3 quarters · filed 2026-08-04 | $34.09M 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.24M 10-Q · filed 2025-11-04 | $14.57M derived: sum of 2 quarters · filed 2026-08-04 | $22.59M 10-Q · filed 2025-11-04 | $30.06M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $7.33M 10-Q · filed 2026-08-04 | $15.35M 10-Q · filed 2026-08-04 | $22.82M derived: sum of 3 quarters · filed 2026-08-04 | $34.56M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $8.01M 10-Q · filed 2026-05-07 | $15.49M derived: sum of 2 quarters · filed 2026-05-07 | $27.23M derived: sum of 3 quarters · filed 2026-05-07 | $32.85M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.22M derived: sum of 2 quarters · filed 2026-02-26 | $24.84M derived: sum of 3 quarters · filed 2026-02-26 | $35.83M 10-K · filed 2026-02-26 |
| 2024-09-30 | $11.74M 10-Q · filed 2025-11-04 | $17.36M derived: sum of 2 quarters · filed 2025-11-04 | $28.36M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $5.62M 10-Q · filed 2025-08-05 | $8.88M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $3.25M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $15.11M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |